Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

NCT00100633 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis B

Interventions

DRUG: CpG7909 oligodeoxynucleotides (ODN)
BIOLOGICAL: Hepatitis B virus vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)